Potential antiretroviral drug interactions with cyclophosphamide, Doxorubicin, and Etoposide.
Bower
Mark
M
Powles
Tom
T
Stebbing
Justin
J
Thirlwell
Christina
C
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004347:Drug Interactions; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced; D011480:Protease Inhibitors
D011480:Protease Inhibitors; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide